Thiazolidinedione - Medicow
About us  |  Why use us?  |  Press  |  Contact us

 

Topic: Thiazolidinedione



  
 [No title]
The inventors propose that local, regional delivery of thiazolidinedione, such as troglitazone, to a patient who may experience or is experiencing an oxytocin-mediated action, such as uterine contractions in labor or lactation, will be a very efficient method for delivering a therapeutically effective composition to counteract the oxytocin action.
Such assays can be used to evaluate the efficacy of thiazolidinedione therapy; alternatively, these assays can be used with the screening methods of the present invention to identify and characterize agonists and antagonists of oxytocin.
thiazolidinedione effective to reduce the oxytocin-mediated action in the subject.
http://www.wipo.int/cgi-pct/guest/getbykey5?KEY=00/25781.000511&ELEMENT_SET=DECL   (9576 words)

  
 Australian Prescriber - Clinical indications for thiazolidinediones
A major question is whether the glycaemic response to thiazolidinediones is maintained longer than with other oral hypoglycaemic drugs.
For patients in the class I or II NYHA categories, thiazolidinediones can probably be prescribed with extreme caution.
7 There is no current evidence to suggest that the glucose-lowering actions of thiazolidinediones are greater than those of other oral hypoglycaemic drugs.
http://www.australianprescriber.com/index.php?content=/magazines/vol27no3/70_74_clinicalthiaz.htm   (2471 words)

  
 Mayo Clinic Proceedings
Our data suggest that thiazolidinediones should be used with caution or avoided in patients with left ventricular dysfunction or chronic renal insufficiency.
Thus, these 6 cases represent 0.9% of patients being treated at our facility with thiazolidinedione therapy.
None of these patients had acute myocardial infarction, pronounced arrhythmia, or other conditions to explain deterioration of cardiac status.
http://www.mayoclinicproceedings.com/inside.asp?AID=404&UID=   (1818 words)

  
 Discovery Health :: Center Article :: Thiazolidinediones
Before you take a thiazolidinedione, tell all your doctors and your pharmacist about all the medicines you take.
Talk with your doctor before you take a thiazolidinedione if you take any other medicines.
Many medicines can have harmful effects when you take them with other medicines.
http://health.discovery.com/centers/articles/articles.html?chrome=c10&article=LC_62¢er=p07   (438 words)

  
 CE: An overview and comparison of the thiazolidinediones - Drug Topics
Therefore, it is difficult to draw conclusions concerning a causal relationship with the drug.
Rosiglitazone and pioglitazone significantly improve glycemic control when used as monotherapy or in combination therapy.
In practice, the incidence is slightly less, but it's not a significant difference.
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=110784   (4269 words)

  
 NGC - NGC Summary
Thiazolidinediones (pioglitazone, rosiglitazone): Because of the potential for hepatotoxicity, caution should be used when starting thiazolidinedione therapy if alanine transaminase levels are mildly elevated (1 to 2.5 times the upper limit of normal) and therapy should not be initiated if alanine transaminase levels are >2.5 times the upper limit of normal.
Discontinue thiazolidinedione therapy if alanine transaminase levels exceed three times the upper limit of normal.
For rosiglitazone and pioglitazone therapy, alanine transaminase levels should be determined every other month for the first year of therapy and periodically thereafter.
http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=4159&nbr=3187   (2202 words)

  
 Thiazolidinedione Effects on Glucocorticoid Receptor-Mediated Gene Transcription and Differentiation in Osteoblastic ...
thiazolidinedione that is being evaluated as a new therapeutic
As thiazolidinediones represent an important new class of drugs,
thiazolidinedione antidiabetic, enhanced the effect of DEX to stimulate
http://endo.endojournals.org/cgi/content/full/140/7/3245   (6282 words)

  
 Nursing Spectrum- Career Fitness Online
For patients in the early stages of CHF who take thiazolidinediones, education about the early signs of worsening heart failure is also critical.
The consensus statements emphasize educating patients to report any weight gain over 6.6 lbs, sudden onset of edema, or shortness of breath.
Nurses are aware of the importance of reminding patients with diabetes that they must not skip meals when they take anti-diabetic agents — it is crucially important to reinforce this message, especially if the patient is also taking gemfibrozil.
http://nsweb.nursingspectrum.com/NurseNewsEzine/DrugNews/item.cfm?ID=109   (402 words)

  
 Mechanism and Implications of Brown Adipose Tissue Proliferation in Rats and Monkeys Treated with the Thiazolidinedione ...
to other thiazolidinediones, to our knowledge no one has reported
profile of specific thiazolidinediones in animals and humans
effects of thiazolidinedione treatment in rats and monkeys
http://jpet.aspetjournals.org/cgi/content/full/305/3/1173   (6340 words)

  
 Rosiglitazone - Wikipedia, the free encyclopedia
Rosiglitazone is an anti-diabetic drug from the thiazolidinedione class.
Another combination drug approved by the FDA is Avandaryl® (with glimepiride).
Like other thiazolidinediones, its mechanism of action is by activation of the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPARγ.
http://en.wikipedia.org/wiki/Rosiglitazone   (194 words)

  
 AVANDIA
Avandia is a drug in the thiazolidinedione class of medication.
Another drug of the thiazolidinedione class, troglitazone, has been associated with idiosyncratic hepatotoxicity, and very rare cases of liver failure, liver transplants, and death have been reported during postmarketing clinical use.
Lower pre-treatment hemoglobin/hematocrit levels in patients enrolled in the metformin combination clinical trials may have contributed to the higher reporting rate of anemia in these studies (see Laboratory Abnormalities, Hematologic).
http://www.diabetic-help.com/avandia.htm   (2978 words)

  
 Rosiglitazone & Pioglitazone Treatment for Lipodystrophy, diabetes, effects on lipids
In contrast to our study, the report by Carr and associates (2) did not demonstrate significant increases in subcutaneous fat after 48 weeks of rosiglitazone therapy compared with placebo in HIV-infected patients with lipoatrophy.
Consistent with these observations, clinical studies have demonstrated that thiazolidinedione therapy in type 2 diabetic patients is associated with weight gain, yet glycemic control improves.
Another drug of the thiazolidinedione class, troglitazone, has been associated with severe hepatotoxicity.
http://www.natap.org/2005/HIV/011005_07.htm   (4346 words)

  
 Abstract: 776
This may be a key mechanism of a secondary failure of thiazolidinedione treatment.
Modifying effects of vitamin A in combination with thiazolidinedione treatment
Vitamin A is reported to contribute to fat deposition in muscle and liver.
http://www.easd.org/customfiles/easd/37th/Abs01/776.html   (361 words)

  
 Triple therapy fights type 2 diabetes without weight gain
It's the first study to analyze the safety and effectiveness of triple therapy using insulin, metformin and a drug in the thiazolidinedione family.
In the UT Southwestern study, however, all 28 patients who used triple therapy reduced their blood-sugar levels below 7 percent without increasing insulin.
Almost 60 percent of all patients, regardless of what order the drugs were taken, reduced HbAlc levels below 6 percent.
http://www.medicalnewstoday.com/medicalnews.php?newsid=9974   (610 words)

  
 Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer (PPAR{gamma} Agonist) Action -- Zierath et al. 139 ...
mechanism for thiazolidinedione action: 1) It is now clear that
Whitcomb RW, Saltiel AR, Lockwood DH 1996 New therapies for non-insulin-dependent diabetes mellitus: thiazolidinediones.
thiazolidinedione to assess the effects of in vivo PPAR
http://endo.endojournals.org/cgi/content/full/139/12/5034   (6027 words)

  
 News - Fluid Retention Reversible In Diabetics With Chronic Systolic Heart Failure Treated With Thiazolidinedione
No differences were seen, however, in the echocardiographic severity of cardiac dysfunction or the baseline New York Heart Association functional class.
In this study of 111 patients treated with thiazolidinedione (TZD), the researchers found no direct link between the baseline degree of severity of HF and the risk of fluid retention, the characteristics of which they sought to define.
A DGReview of :"Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure"
http://www.docguide.com/news/content.nsf/news/8525697700573E1885256D120031828C   (492 words)

  
 TPNA - Press Releases
These data further support the long-term efficacy of ACTOS, the number one prescribed drug in the thiazolidinedione (TZD) class.
ACTOS is an oral treatment for type 2 diabetes belonging to the thiazolidinedione class of drugs.
It is known as an “insulin sensitizer” because it directly targets insulin resistance, a condition where the body does not produce enough insulin or does not effectively use the insulin it produces.
http://www.tpna.com/prdetail.asp?articleid=90   (1133 words)

  
 THIAZOLIDINEDIONE
The medication class of thiazolidinedione was introduced in the late 1990s as an adjunctive therapy for diabetes mellitus and related diseases.
Therefore, thiazolidinediones cannot be prescribed in patients with decreased ventricular function.
Troglitazone was withdrawn from the market due to an increased incidence of drug-induced hepatitis in patients who were using the drug.
http://www.yotor.org/wiki/en/th/Thiazolidinedione.htm   (265 words)

  
 Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione ...
two thiazolidinediones now in clinical use, seems to have more
is possible that thiazolidinedione modification of the function
Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe -- Colca et al.
http://ajpendo.physiology.org/cgi/content/abstract/286/2/E252   (331 words)

  
 Diabetes Monitor - rosiglitazone (Avandia)
Avandia (rosiglitazone) is a thiazolidinedione medication for the therapy of
When using AVANDIA in combination with other hypoglycemic agents, the risk of hypoglycemia, its symptoms and treatment, and conditions that predispose to its development should be explained to patients and their family members.
Therapy with AVANDIA, like other thiazolidinediones, may result in ovulation in some premenopausal anovulatory women.
http://www.diabetesmonitor.com/avandia.htm   (705 words)

  
 Starlix(R) Approved For Use in Combination with Popular Thiazolidinedione Class of Antidiabetic Drugs
Terms and conditions, including restrictions on redistribution, apply.
Starlix(R) Approved For Use in Combination with Popular Thiazolidinedione Class of Antidiabetic Drugs
TZDs are a commonly used class of oral antidiabetic agents in the treatment of type 2 diabetes.
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/10-23-2003/0002042489&EDATE=   (667 words)

  
 Unilateral Edema Due to a Thiazolidinedione -- Bell 26 (9): 2700 -- Diabetes Care
In conclusion, practitioners need to be aware that dependent
Dependent edema is a side effect of thiazolidinediones due to
edema due to thiazolidinediones can present with unilateral
http://care.diabetesjournals.org/cgi/content/full/26/9/2700   (487 words)

  
 A Selective Peroxisome Proliferator-Activated Receptor-{gamma} (PPAR{gamma}) Modulator Blocks Adipocyte Differentiation ...
the thiazolidinediones, leads to increased adiposity and body
such as the thiazolidinediones are insulin sensitizers used
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
http://mend.endojournals.org/cgi/content/full/14/9/1425   (3779 words)

  
 Inhibitory Activity of Clinical Thiazolidinedione Peroxisome Proliferator Activating Receptor-{gamma} Ligands Toward ...
Inhibition of proliferation of VSMCs treated with thiazolidinediones (TZDs).
Thiazolidinediones are the latest class of drugs for the treatment
Inhibition of proliferation of VSMCs treated with thiazolidinediones (TZDs) is cell cycle-dependent.
http://circ.ahajournals.org/cgi/content/full/107/20/2548   (1911 words)

  
 The Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly ...
of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients
The Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly Controlled with Sulfonylurea and Metformin: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial -- Yale et al.
Why did the researchers do this particular study?
http://www.annals.org/cgi/content/summary/134/9_Part_1/737   (709 words)

  
 Alzforum: News
The sixth patient was also given diuretics but thiazolidinedione treatment continued.
In the present study, the six patients represent less than one percent of patients treated with the drugs at the Veterans Center.
Thirteen months later, he returned with the same symptoms, was again given diuretics and this time the thiazolidinedione treatment was halted.
http://www.alzforum.org/new/detail.asp?id=870   (849 words)

  
 Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects -- Wilmsen et ...
Chronic regulation of FFA uptake and oxidation: effects of thiazolidinedione treatment.
The aim of the present study was to study the regulation of
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.
http://ajpendo.physiology.org/cgi/content/full/285/2/E354   (6053 words)

  
 Is Rosiglitazone Hepatotoxic, Too? - Journal Watch (General)
Nonetheless, because these cases raise the possibility that the thiazolidinedione class may be hepatotoxic, physicians and patients should be aware of and remain alert for possible hepatic damage from this new drug.
Rosiglitazone -- another thiazolidinedione -- has not previously been associated with hepatotoxicity, but 2 cases of liver injury possibly due to rosiglitazone have now been reported.
Forman LM et al Hepatic failure in a patient taking rosiglitazone Ann Intern Med 2000 Jan 18; 132:118-121.
http://general-medicine.jwatch.org/cgi/content/full/2000/201/1   (287 words)

  
 Diabetes Scene
The thiazolidinedione, which include ciglitazone and pioglitazone as well as troglitazone, have a beneficial effect on insulin resistance and may actually be useful for preventing NIDDM.
One of the most interesting new drugs being tested for NIDDM is troglitazone, a member of the thiazolidinedione class of anti-diabetic agents.
The thiazolidinedione have been shown to reduce elevated plasma glucose, triglycerides, and insulin concentrations in animals with hyperinsulinemia and to improve both fasting and postprandial hyperglycemia and hyperinsulinemia in patients with NIDDM.
http://www.banting.com/rcenter/thiazon.html   (430 words)

  
 dlife.com - Thiazolidinedione Drugs for Type 2 Diabetes
Or you may take a thiazolidinedione as your only diabetes medicine.
Yes, your health care provider may ask you to take another diabetes medicine along with a thiazolidinedione.
Call your doctor right away if you have any signs of liver disease: nausea, vomiting, stomach pain, lack of appetite, tiredness, yellowing of the skin or whites of the eyes, or dark-colored urine.
http://www.dlife.com/dLife/do/ShowContent/about_diabetes/type_2/treatment/oral_medication/thiazolidinedione   (355 words)

  
 FDA Approves Rosiglitazone to Treat Type II Diabetes
Mild to moderate edema, an increase in blood cholesterol and anemia were also reported in patients treated with rosiglitazone, but did not usually require discontinuation of treatment.
FDA has approved rosiglitazone (Avandia), a new drug in the thiazolidinedione class of drugs to treat type II diabetes.
Another drug of the thiazolidinedione class, Rezulin (troglitazone, manufactured by Parke-Davis), has been associated with idiosyncratic hepatotoxicity, or liver failure.
http://www.fda.gov/bbs/topics/ANSWERS/ANS00957.html   (474 words)

  
 Troglitazone, an Insulin-Sensitizing Thiazolidinedione, Represses Combined Stimulation by LH and Insulin of de Novo ...
thiazolidinedione compounds in patients with PCOS and further
is activated by inducers of adipogenesis, including thiazolidinedione drugs.
Troglitazone, an Insulin-Sensitizing Thiazolidinedione, Represses Combined Stimulation by LH and Insulin of de Novo Androgen Biosynthesis by Thecal Cells in Vitro -- Veldhuis et al.
http://jcem.endojournals.org/cgi/content/full/87/3/1129   (3303 words)

  
 Diabetes: The Antidiabetic Effects of CI-1037/CS011, a Ne... @ HighBeam Research
The Antidiabetic Effects of CI-1037/CS011, a New Thiazolidinedione.
These data show that CI-1037/CS-011 both prevents and treats diabetes in the ZDF rat model and is the most potent of the thiazolidinedione class of insulin sensitizers.
Diabetes; 5/1/2000; JOHNSON, JOHN H. The thiazolidinediones represent a class of compounds that directly decrease insulin resistance by enhancing insulin action in skeletal muscle, adipose tissue and liver.
http://www.highbeam.com/library/doc0.asp?DOCID=1G1:62891727&refid=holomed_1   (434 words)

  
 Clinical Trial: Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to ...
Patients who had an increase in their thiazolidinedione medication within 2 months of entering the study (Visit 0).
The purpose of this study is to assess the efficacy and safety of Amaryl when added to Metformin and Thiazolidinedione (TZD) in non-insulin dependent diabetes mellitus (NIDDM) patients.
Official Title: A Double-Blind, Placebo-Controlled, Parallel Group Comparison Study to Evaluate the Role of the Addition of Amaryl to NIDDM Patients Not Responding to Maximum Dose Metformin and Thiazolidinedione Therapy
http://www.clinicaltrials.gov/ct/show/NCT00044447   (638 words)

  
 Type 2 diabetes in Alstrom syndrome: Targeting insulin resistance with a thiazolidinedione
Rosiglitazone improved glycaemic control in our patient with Alstrom syndrome though this was associated with deterioration in lipid control and progressive weight gain.
Thiazolidinediones are highly effective in reducing insulin resistance.
Total cholesterol and serum triglycerides have increased from 6.28mmol/l and 3.71mmol/l to 9.02 mmol/l and 6.94 mmol/l respectively over the same period.
http://www.endocrine-abstracts.org/ea/0005/ea0005p104.htm   (306 words)

  
 Thiazolidinedione Compounds Ameliorate Glomerular Dysfunction Independent of Their Insulin-Sensitizing Action in ...
Thiazolidinedione Compounds Ameliorate Glomerular Dysfunction Independent of Their Insulin-Sensitizing Action in Diabetic Rats (NDEI.ORG)
Thiazolidinedione Compounds Ameliorate Glomerular Dysfunction Independent of Their Insulin-Sensitizing Action in Diabetic Rats
Herein, we provide evidence showing that troglitazone, one of the TZD compounds, is able to prevent glomerular dysfunction in diabetic rats through a novel mechanism independent of its insulin-sensitizing action.
http://www.ndei.org/v2/website/litalerts/article.cfm?article_id=32   (335 words)

  
 Retinoid X receptor-{gamma} and peroxisome proliferator-activated receptor-{gamma} expression predicts thyroid ...
and increased apoptosis when treated with ciglitazone (a thiazolidinedione).
expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment
and the target for the thiazolidinedione class of drugs used
http://mct.aacrjournals.org/cgi/content/full/3/8/1011   (4514 words)

  
 The Diabetes Educator -- Sign In Page
Early Combination Therapy With a Thiazolidinedione for the Treatment of Type 2 Diabetes
CONTACT US Copyright © 2003 by American Association of Diabetes Educators; Published by SAGE Publications Privacy Policy
http://tde.sagepub.com/cgi/reprint/29/6/954   (229 words)

  
 Diabetes Research Summary - Insulin Resistance Leads to Abnormal Heart Function - American Diabetes Association
None of them showed any risk factors or symptoms for heart disease.
The group taking thiazolidinedione for 3 months improved their insulin sensitivity, decreased their insulin levels, and their heart blood flow returned to normal.
Insulin-resistant people can have problems with their blood vessels even without having any other heart risk factors.
http://www.diabetes.org/diabetes-research/summaries/quinones-insulinresistance.jsp   (314 words)

  
 Thiazolidinedione definition - Medical Dictionary definitions of popular medical terms
Thiazolidinedione definition - Medical Dictionary definitions of popular medical terms
MedicineNet Home > MedTerms medical dictionary A-Z List > Thiazolidinedione
Thiazolidinedione: (Pronounced THIGH-ah-ZO-li-deen-DYE-own.) A class of drugs for type 2 diabetes that lower the blood sugar by increasing the sensitivity of cells to insulin.
http://www.medterms.com/script/main/art.asp?articlekey=25205   (282 words)

  
 BioCarta - Charting Pathways of Life
The natural ligand 15-deoxy prostaglandin J2 stimulated PPAR-gamma interaction with SRC-1, TIF2, TRAP220, and p300, while the synthetic PPAR-gamma ligand troglitazone, an antidiabetic thiazolidinedione drug, did not promote these interactions, indicating that other distinct coactivators may mediate the response to PPAR-gamma when it binds this ligand.
PPAR-gamma is a member of this gene family that is activated by fatty acids and thiazolidinedione drugs that plays a role in insulin sensitivity and adipogenesis (See Visceral Fat Deposits and the Metabolic Syndrome pathway).
Some PPAR-gamma ligands induce the specific recruitment of coactivators, and might evoke different functional responses based on the interactions they favor.
http://www.biocarta.com/pathfiles/h_ppargPathway.asp   (566 words)

  
 Starlix - Press Release
Novartis Pharmaceuticals Corporation researches, develops, manufacturers and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including diabetes, central nervous system disorders, organ transplantation, cardiovascular diseases, dermatological diseases, respiratory disorders, cancer and arthritis.
Combination therapy with a thiazolidinedione provides new option for controlling and maintaining blood sugar levels in type 2 diabetes
Research has shown that improved glycemic control, as measured by a reduction of HbA1c levels, may lead to a dramatic lowering of deaths and complications from diabetes.
http://www.pharma.us.novartis.com/newsroom/pressReleases/releaseDetail.jsp?PRID=1063   (375 words)

  
 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease ...
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus (US5874454)
http://www.delphion.com/details?pn=US05874454__&language=en   (316 words)

  
 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant ...
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus (US5708012)
http://www.delphion.com/details?pn=US05708012__&language=en   (343 words)

  
 Ohyama et al., January 1998
These results showed that the thiazolidinedione stimulated adipocyte differentiation and the retinoids blocked the adipogenesis induced by the thiazolidinedione in primary culture of bovine SV cells.
Peroxisome proliferator-activated receptor gamma may play an important role in adipocyte differentiation, and retinoids may interfere with the action of PPARgamma in cattle.
Understanding the action of PPARgamma ligand and retinoids in bovine adipocytes will contribute to our understanding of adipose development in meat animals and meat production.
http://www.asas.org/jas/abs/1998/jan61abs.html   (347 words)

  
 Process Development and Scale-Up of the Potential Thiazolidinedione Antidiabetic Candidate PNU-91325
This process involves a novel epoxide ring opening with a deactivated phenol under phase-transfer conditions.
An efficient six-step synthesis has been developed for the preparation of the thiazolidinedione analogue PNU-91325 (3) from the commercially available olefin 12.
Process Development and Scale-Up of the Potential Thiazolidinedione Antidiabetic Candidate PNU-91325
http://pubs.acs.org/cgi-bin/abstract.cgi/oprdfk/2002/6/i05/abs/op025549s.html   (145 words)

  
 Clinical Trial: Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With ...
Official Title: Substituting Lantus®(Insulin Glargine[rDNAorigin]Inj) for a Thiazolidinedione Vs. a 3rd Oral Agent as Add-on Therapy in Patients Failing a Thiazolidinedione and Sulfonylurea or Metformin Combination
The purposes of the study is to determine whether blood sugar control is different between Lantus and a third oral anti-diabetic agent when added to patients who fail a thiazolidinedione and sulfonylurea or metformin combination.
Ages Eligible for Study: 18 Years - 79 Years, Genders Eligible for Study: Both
http://clinicaltrials.gov/ct/show/NCT00046462?order=39   (192 words)

  
 TPNA - Press Releases
Takeda is the originator of thiazolidinedione derivatives and Actos
Metformin acts primarily by reducing the amount of glucose produced by the liver.
is a member of the thiazolidinedione class of "insulin-sensitizing" agents, and it directly targets insulin resistance.
http://www.tpna.com/prdetail.asp?articleid=104   (353 words)

  
 PAT5A: A Partial Agonist of Peroxisome Proliferator-Activated Receptor {gamma} Is a Potent Antidiabetic ...
role of this novel thiazolidinedione in the treatment of type-2
Is a Potent Antidiabetic Thiazolidinedione Yet Weakly Adipogenic
Berger J, Bailey P, Biswas C, Cullinan CA, Doebber TW, Hayes NS, Saperstein R, Smith RG, and Leibowitz MD (1996) Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
http://jpet.aspetjournals.org/cgi/content/full/306/2/763   (4019 words)

  
 EFFECT OF THIAZOLIDINEDIONE (TZD) RING MODIFICATION ON 3-(3,5-DICHLOROPHENYL)-2,4-THIAZOLIDINEDIONE (DCPT) INDUCED ...
Previously, we observed that DCPT caused hepatotoxicity in F344 rats.
This suggests that an intact TZD ring is critical for toxicity; however, this will require further investigation.
EFFECT OF THIAZOLIDINEDIONE (TZD) RING MODIFICATION ON 3-(3,5-DICHLOROPHENYL)-2,4-THIAZOLIDINEDIONE (DCPT) INDUCED HEPATOTOXICITY IN RATS
http://www.usip.edu/research/scholarlyday/abstractDetail.asp?id=94   (357 words)

 About us   |  Why use us?   |  Press   |  Contact us

 Copyright © 2006 Medicow.com Usage implies agreement with terms.